Ribonucleic Acid Ingredients - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509247779

Publication Date:

September 5, 2024

Pages:

111

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

A synthesized from DNA by an enzyme known as RNA polymerase during a process called transcription.
The global market for Ribonucleic Acid Ingredients was estimated to be worth US$ 3350 million in 2023 and is forecast to a readjusted size of US$ 5223.9 million by 2030 with a CAGR of 6.6% during the forecast period 2024-2030
The global ribonucleic acid (RNA) ingredients market refers to the industry involved in the production and distribution of various RNA-based ingredients used in different sectors, including pharmaceuticals, biotechnology, agriculture, and research laboratories. RNA ingredients play a crucial role in a wide range of applications, including therapeutic development, gene expression analysis, genetic engineering, and molecular diagnostics.
Here are some key insights into the global RNA ingredients market:
麻豆原创 Overview:
The global RNA ingredients market has been witnessing steady growth due to the increasing adoption of RNA-based technologies in various industries. RNA ingredients are widely used for their ability to regulate gene expression, perform cellular functions, and as tools in molecular biology research.
Types of RNA Ingredients:
The market for RNA ingredients can be categorized based on their types, including:
Messenger RNA (mRNA): mRNA is a form of RNA that carries genetic information from DNA to the ribosomes, where it is used as a template for protein synthesis. mRNA ingredients find applications in vaccine development, gene therapy, and regenerative medicine.
Transfer RNA (tRNA): tRNA molecules play a crucial role in protein synthesis by delivering amino acids to the ribosomes. tRNA ingredients are used in various research and diagnostic applications involving protein synthesis and translation.
Ribosomal RNA (rRNA): rRNA molecules are a component of ribosomes, the cellular machinery responsible for protein synthesis. rRNA ingredients find applications in research laboratories and biotechnological processes involved in protein production.
Small Interfering RNA (siRNA): siRNA molecules are used in genetic research and therapeutics to selectively inhibit the expression of target genes. siRNA ingredients have potential applications in disease treatment, including cancer therapy and genetic disorders.
Applications:
RNA ingredients have a wide range of applications in various industries:
Pharmaceuticals and Biotechnology: RNA ingredients are extensively used in drug discovery, therapeutic development (including mRNA-based vaccines and gene therapy), and personalized medicine. RNA-based technologies offer new possibilities for treating diseases at the genetic level.
Agriculture and Crop Science: RNA ingredients are explored for their potential in genetic engineering and crop improvement. They can be used to modify gene expression in plants, enhancing traits such as disease resistance, yield, and nutritional content.
Research and Diagnostics: RNA ingredients are valuable tools in research laboratories for gene expression analysis, studying cellular processes, and understanding disease mechanisms. They are also used in molecular diagnostics to detect specific RNA sequences associated with diseases.
麻豆原创 Dynamics:
The global RNA ingredients market is influenced by several factors, including:
Advancements in RNA-based technologies and their increasing adoption across industries.
Growing demand for personalized medicine and targeted therapies.
Government initiatives and funding for RNA research and development.
Increased focus on genetic engineering and genetically modified organisms in agriculture.
麻豆原创 Outlook:
The global RNA ingredients market is expected to witness continued growth in the coming years, driven by ongoing advancements in RNA-based technologies, increasing research activities, and rising demand for personalized medicine. The market is likely to see new product launches, collaborations, and strategic partnerships as companies strive to innovate and cater to the evolving needs of different industries.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Ribonucleic Acid Ingredients, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Ribonucleic Acid Ingredients by region & country, by Type, and by Application.
The Ribonucleic Acid Ingredients market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ribonucleic Acid Ingredients.
麻豆原创 Segmentation
By Company
BioNTech SE
Moderna
Abogen Biosciences
Ionis Pharmaceuticals
Sarepta Therapeutics
Alnylam Pharmaceuticals
LARONDE, Inc.
Sirnaomics, Inc.
Deep Genomics
Nutcracker Therapeutics
Segment by Type:
Messenger RNA
Transfer RNA
Ribosomal RNA
Segment by Application
Fluorescent Dyes
RT-PCR Enzymes
Transcription Reagents
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Ribonucleic Acid Ingredients manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Ribonucleic Acid Ingredients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Ribonucleic Acid Ingredients in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Ribonucleic Acid Ingredients Product Introduction
1.2 Global Ribonucleic Acid Ingredients 麻豆原创 Size Forecast
1.3 Ribonucleic Acid Ingredients 麻豆原创 Trends & Drivers
1.3.1 Ribonucleic Acid Ingredients Industry Trends
1.3.2 Ribonucleic Acid Ingredients 麻豆原创 Drivers & Opportunity
1.3.3 Ribonucleic Acid Ingredients 麻豆原创 Challenges
1.3.4 Ribonucleic Acid Ingredients 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Ribonucleic Acid Ingredients Players Revenue Ranking (2023)
2.2 Global Ribonucleic Acid Ingredients Revenue by Company (2019-2024)
2.3 Key Companies Ribonucleic Acid Ingredients Manufacturing Base Distribution and Headquarters
2.4 Key Companies Ribonucleic Acid Ingredients Product Offered
2.5 Key Companies Time to Begin Mass Production of Ribonucleic Acid Ingredients
2.6 Ribonucleic Acid Ingredients 麻豆原创 Competitive Analysis
2.6.1 Ribonucleic Acid Ingredients 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Ribonucleic Acid Ingredients Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ribonucleic Acid Ingredients as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Messenger RNA
3.1.2 Transfer RNA
3.1.3 Ribosomal RNA
3.2 Global Ribonucleic Acid Ingredients Sales Value by Type
3.2.1 Global Ribonucleic Acid Ingredients Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Ribonucleic Acid Ingredients Sales Value, by Type (2019-2030)
3.2.3 Global Ribonucleic Acid Ingredients Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Fluorescent Dyes
4.1.2 RT-PCR Enzymes
4.1.3 Transcription Reagents
4.1.4 Others
4.2 Global Ribonucleic Acid Ingredients Sales Value by Application
4.2.1 Global Ribonucleic Acid Ingredients Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Ribonucleic Acid Ingredients Sales Value, by Application (2019-2030)
4.2.3 Global Ribonucleic Acid Ingredients Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Ribonucleic Acid Ingredients Sales Value by Region
5.1.1 Global Ribonucleic Acid Ingredients Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Ribonucleic Acid Ingredients Sales Value by Region (2019-2024)
5.1.3 Global Ribonucleic Acid Ingredients Sales Value by Region (2025-2030)
5.1.4 Global Ribonucleic Acid Ingredients Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Ribonucleic Acid Ingredients Sales Value, 2019-2030
5.2.2 North America Ribonucleic Acid Ingredients Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Ribonucleic Acid Ingredients Sales Value, 2019-2030
5.3.2 Europe Ribonucleic Acid Ingredients Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Ribonucleic Acid Ingredients Sales Value, 2019-2030
5.4.2 Asia Pacific Ribonucleic Acid Ingredients Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Ribonucleic Acid Ingredients Sales Value, 2019-2030
5.5.2 South America Ribonucleic Acid Ingredients Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Ribonucleic Acid Ingredients Sales Value, 2019-2030
5.6.2 Middle East & Africa Ribonucleic Acid Ingredients Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Ribonucleic Acid Ingredients Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Ribonucleic Acid Ingredients Sales Value
6.3 United States
6.3.1 United States Ribonucleic Acid Ingredients Sales Value, 2019-2030
6.3.2 United States Ribonucleic Acid Ingredients Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Ribonucleic Acid Ingredients Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Ribonucleic Acid Ingredients Sales Value, 2019-2030
6.4.2 Europe Ribonucleic Acid Ingredients Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Ribonucleic Acid Ingredients Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Ribonucleic Acid Ingredients Sales Value, 2019-2030
6.5.2 China Ribonucleic Acid Ingredients Sales Value by Type (%), 2023 VS 2030
6.5.3 China Ribonucleic Acid Ingredients Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Ribonucleic Acid Ingredients Sales Value, 2019-2030
6.6.2 Japan Ribonucleic Acid Ingredients Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Ribonucleic Acid Ingredients Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Ribonucleic Acid Ingredients Sales Value, 2019-2030
6.7.2 South Korea Ribonucleic Acid Ingredients Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Ribonucleic Acid Ingredients Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Ribonucleic Acid Ingredients Sales Value, 2019-2030
6.8.2 Southeast Asia Ribonucleic Acid Ingredients Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Ribonucleic Acid Ingredients Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Ribonucleic Acid Ingredients Sales Value, 2019-2030
6.9.2 India Ribonucleic Acid Ingredients Sales Value by Type (%), 2023 VS 2030
6.9.3 India Ribonucleic Acid Ingredients Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 BioNTech SE
7.1.1 BioNTech SE Profile
7.1.2 BioNTech SE Main Business
7.1.3 BioNTech SE Ribonucleic Acid Ingredients Products, Services and Solutions
7.1.4 BioNTech SE Ribonucleic Acid Ingredients Revenue (US$ Million) & (2019-2024)
7.1.5 BioNTech SE Recent Developments
7.2 Moderna
7.2.1 Moderna Profile
7.2.2 Moderna Main Business
7.2.3 Moderna Ribonucleic Acid Ingredients Products, Services and Solutions
7.2.4 Moderna Ribonucleic Acid Ingredients Revenue (US$ Million) & (2019-2024)
7.2.5 Moderna Recent Developments
7.3 Abogen Biosciences
7.3.1 Abogen Biosciences Profile
7.3.2 Abogen Biosciences Main Business
7.3.3 Abogen Biosciences Ribonucleic Acid Ingredients Products, Services and Solutions
7.3.4 Abogen Biosciences Ribonucleic Acid Ingredients Revenue (US$ Million) & (2019-2024)
7.3.5 Ionis Pharmaceuticals Recent Developments
7.4 Ionis Pharmaceuticals
7.4.1 Ionis Pharmaceuticals Profile
7.4.2 Ionis Pharmaceuticals Main Business
7.4.3 Ionis Pharmaceuticals Ribonucleic Acid Ingredients Products, Services and Solutions
7.4.4 Ionis Pharmaceuticals Ribonucleic Acid Ingredients Revenue (US$ Million) & (2019-2024)
7.4.5 Ionis Pharmaceuticals Recent Developments
7.5 Sarepta Therapeutics
7.5.1 Sarepta Therapeutics Profile
7.5.2 Sarepta Therapeutics Main Business
7.5.3 Sarepta Therapeutics Ribonucleic Acid Ingredients Products, Services and Solutions
7.5.4 Sarepta Therapeutics Ribonucleic Acid Ingredients Revenue (US$ Million) & (2019-2024)
7.5.5 Sarepta Therapeutics Recent Developments
7.6 Alnylam Pharmaceuticals
7.6.1 Alnylam Pharmaceuticals Profile
7.6.2 Alnylam Pharmaceuticals Main Business
7.6.3 Alnylam Pharmaceuticals Ribonucleic Acid Ingredients Products, Services and Solutions
7.6.4 Alnylam Pharmaceuticals Ribonucleic Acid Ingredients Revenue (US$ Million) & (2019-2024)
7.6.5 Alnylam Pharmaceuticals Recent Developments
7.7 LARONDE, Inc.
7.7.1 LARONDE, Inc. Profile
7.7.2 LARONDE, Inc. Main Business
7.7.3 LARONDE, Inc. Ribonucleic Acid Ingredients Products, Services and Solutions
7.7.4 LARONDE, Inc. Ribonucleic Acid Ingredients Revenue (US$ Million) & (2019-2024)
7.7.5 LARONDE, Inc. Recent Developments
7.8 Sirnaomics, Inc.
7.8.1 Sirnaomics, Inc. Profile
7.8.2 Sirnaomics, Inc. Main Business
7.8.3 Sirnaomics, Inc. Ribonucleic Acid Ingredients Products, Services and Solutions
7.8.4 Sirnaomics, Inc. Ribonucleic Acid Ingredients Revenue (US$ Million) & (2019-2024)
7.8.5 Sirnaomics, Inc. Recent Developments
7.9 Deep Genomics
7.9.1 Deep Genomics Profile
7.9.2 Deep Genomics Main Business
7.9.3 Deep Genomics Ribonucleic Acid Ingredients Products, Services and Solutions
7.9.4 Deep Genomics Ribonucleic Acid Ingredients Revenue (US$ Million) & (2019-2024)
7.9.5 Deep Genomics Recent Developments
7.10 Nutcracker Therapeutics
7.10.1 Nutcracker Therapeutics Profile
7.10.2 Nutcracker Therapeutics Main Business
7.10.3 Nutcracker Therapeutics Ribonucleic Acid Ingredients Products, Services and Solutions
7.10.4 Nutcracker Therapeutics Ribonucleic Acid Ingredients Revenue (US$ Million) & (2019-2024)
7.10.5 Nutcracker Therapeutics Recent Developments
8 Industry Chain Analysis
8.1 Ribonucleic Acid Ingredients Industrial Chain
8.2 Ribonucleic Acid Ingredients Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Ribonucleic Acid Ingredients Sales Model
8.5.2 Sales Channel
8.5.3 Ribonucleic Acid Ingredients Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

BioNTech SE
Moderna
Abogen Biosciences
Ionis Pharmaceuticals
Sarepta Therapeutics
Alnylam Pharmaceuticals
LARONDE, Inc.
Sirnaomics, Inc.
Deep Genomics
Nutcracker Therapeutics

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.